TickerFactsScreenerDevelopers

Corvus Pharmaceuticals, Inc. (CRVS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$11.33M2016: -$27.86M2017: -$46.21M2018: -$40.99M2019: -$37.32M2020: -$34.78M2021: -$36.72M2022: -$27.02M2023: -$23.93M2024: -$25.42M2025: -$32.80M-$32.80M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$32.80M-29.0%
2024-$25.42M-6.2%
2023-$23.93M+11.4%
2022-$27.02M+26.4%
2021-$36.72M-5.6%
2020-$34.78M+6.8%
2019-$37.32M+8.9%
2018-$40.99M+11.3%
2017-$46.21M-65.9%
2016-$27.86M-145.9%
2015-$11.33M—